Use of Genetically Engineered Mice to Study the Biology of Huntingtin

Movement Disorders: Genetics and Models: Second Edition

Volumn , Issue , 2015, Pages 547-555

  Dietrich, Paula ^a   Dragatsis, Ioannis ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Huntingtin; Huntington disease; Mouse models; Neurodegeneration; Neuroprotection

Indexed keywords

EID: 84943264955     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405195-9.00032-9     Document Type: Chapter

References (68)

1. Andrade M.A., Bork P. HEAT repeats in the Huntington's disease protein. Nat. Genet. 1995, 1:115-116.
2. Auerbach W., Hurlbert M.S., Hilditch-Maguire P., Wadghiri Y.Z., Wheeler V.C., Cohen S.I., Joyner A.L., MacDonald M.E., Turnbull D.H. The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum. Mol. Genet. 2001, 10:2515-2523.
3. Aziz N.A., van der Burg J.M., Landwehrmeyer G.B., Brundin P., Stijnen T. EHDI Study Group, Roos RA. Weight loss in Huntignton disease increases with higher CAG repeat number. Neurology 2008, 71:1506-1513.
4. Barnes G.T., Duyao M.P., Ambrose C.M., McNeil S., Persichetti F., Srinidhi J., Gusella J.F., MacDonald M.E. Mouse Huntington's disease gene homolog (Hdh). Somat. Cell Mol. Genet. 1994, 20:87-97.
5. Bhide P.G., Day M., Sapp E., Schwarz C., Sheth A., Kim J., Young A.B., Penney J., Golden J., Aronin N., DiFiglia M. Expression of normal and mutant huntingtin in the developing brain. J. Neurosci. 1996, 16:5523-5535.
6. Buraczynska M.J., Van Keuren M.L., Buraczynska K.M., Chang Y.S., Crombez E., Kurnit D.M. Construction of human embryonic cDNA libraries: HD, PKD1 and BRCA1 are transcribed widely during embryogenesis. Cytogenet. Cell Genet. 1995, 71:197-202.
7. van der Burg J.M., Bacos K., Wood N.I., Lindqvist A., Wierup N., Woodman B., Wamsteeker J.I., Smith R., Deierborg T., Kuhar M.J., Bates G.P., Mulder H., Erlanson-Albertsson C., Morton A.J., Brundin P., Petersén A., Björkqvist M. Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol. Dis. 2008, 29:41-51.
8. van der Burg J.M., Björkqvist M., Brundin P. Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurol. 2009, 8:765-774.
9. Clabough E.B., Zeitlin S.O. Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. Hum. Mol. Genet. 2006, 15:607-623.
10. Dietrich P., Shanmugasundaram R., Shuyu E., Dragatsis I. Congenital hydrocephalus associated with abnormal subcommissural organ in mice lacking huntingtin in Wnt1 cell lineages. Hum. Mol. Genet. 2009, 18:142-150.
11. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.P., Carraway R., Reeves S.A., et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995, 14:1075-1081.
12. Djoussé L., Knowlton B., Cupples L.A., Marder K., Shoulson I., Myers R.H. Weight loss in the early stage of Huntington's disease. Neurology 2002, 59:1325-1330.
13. Dorsman J.C., Smoor M.A., Maat-Schieman M.L., Bout M., Siesling S., van Duinen S.G., Verschuuren J.J., den Dunnen J.T., Roos R.A., van Ommen G.J. Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 1999, 354:1061-1067.
14. Dragatsis I., Efstratiadis A., Zeitlin S. Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues. Development 1998, 125:1529-1539.
15. Dragatsis I., Levine M.S., Zeitlin S. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 2000, 26:300-306.
16. Dragatsis I., Zeitlin S. CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain. Genesis 2000, 26:133-135.
17. Dragatsis I., Zeitlin S. A method for the generation of conditional gene repais mutations in mice. Nucleic Acids Res. 2001, 29. E10.
18. Duyao M.P., Auerbach A.B., Ryan A., Persichetti F., Barnes G.T., McNeil S.M., Ge P., Vonsattel J.P., Gusella J.F., Joyner A.L., et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995, 269:407-410.
19. Gauthier L.R., Charrin B.C., Borrell-Pagès M., Dompierre J.P., Rangone H., Cordelières F.P., De Mey J., MacDonald M.E., Lessmann V., Humbert S., Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004, 118:127-138.
20. Godin J.D., Colombo K., Molina-Calavita M., Keryer G., Zala D., Charrin B.C., Dietrich P., Volvert M.L., Guillemot F., Dragatsis I., Bellaiche Y., Saudou F., Nguyen L., Humbert S. Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 2010, 67:392-406.
21. Gusella J.F., MacDonald M.E. Huntingtin: a single bait hooks many species. Curr. Opin. Neurobiol. 1998, 8:425-430.
22. Gutekunst C.A., Levey A.I., Heilman C.J., Whaley W.L., Yi H., Nash N.R., Rees H.D., Madden J.J., Hersch S.M. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:8710-8714.
23. Harjes P., Wanker E.E. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci. 2003, 28:425-433.
24. Heng M.Y., Tallaksen-Greene S.J., Detloff P.J., Albin R.L. Longitudinal evaluation of the Hdh(CAG)150-knock-in murine model of Huntington's disease. J. Neurosci. 2007, 27:8989-8998.
25. Hilditch-Maguire P., Trettel F., Passani L.A., Auerbach A., Persichetti F., MacDonald M.E. Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum. Mol. Genet. 2000, 9:2789-2797.
26. Keryer G., Pineda J.R., Liot G., Kim J., Dietrich P., Benstaali C., Smith K., Cordelières F.P., Spassky N., Ferrante R.J., Dragatsis I., Saudou F. Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. J. Clin. Invest. 2011, 121:4372-4382.
27. Kremer H.P., Roos R.A. Weight loss in Huntington's disease. Arch. Neurol. 1992, 49:349.
28. Leavitt B.R., Guttman J.A., Hodgson J.G., Kimel G.H., Singaraja R., Vogl A.W., Hayden M.R. Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am. J. Hum. Genet. 2001, 68:313-324.
29. Leavitt B.R., van Raamsdonk J.M., Shehadeh J., Fernandes H., Murphy Z., Graham R.K., Wellington C.L., Raymond L.A., Hayden M.R. Wild-type huntingtin protects neurons from excitotoxicity. J. Neurochem. 2006, 96:1121-1129.
30. Li Z., Karlovich C.A., Fish M.P., Scott M.P., Myers R.M. A putative Drosophila homolog of the Huntington's disease gene. Hum. Mol. Genet. 1999, 8:1807-1815.
31. Lumsden A.L., Henshall T.L., Dayan S., Lardelli M.T., Richards R.I. Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum. Mol. Genet. 2007, 16:1905-1920.
32. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
33. Morales L.M., Estévez J., Suárez H., Villalobos R., Chacín de Bonilla L., Bonilla E. Nutritional evaluation of Huntington disease patients. Am. J. Clin. Nutr. 1989, 50:145-150.
34. Musacchio T., Torchilin V.P. siRNA delivery: from basics to therapeutic applications. Front. Biosci. 2013, 18:58-79.
35. Nasir J., Floresco S.B., O'Kusky J.R., Diewert V.M., Richman J.M., Zeisler J., Borowski A., Marth J.D., Phillips A.G., Hayden M.R. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995, 81:811-823.
36. Neveklovska M., Clabough E.B., Steffan J.S., Zeitlin S.O. Deletion of the huntingtin proline-rich region does not significantly affect normal huntingtin function in mice. J. Huntingtons Dis. 2012, 1:71-87.
37. Pouladi M.A., Xie Y., Skotte N.H., Ehrnhoefer D.E., Graham R.K., Kim J.E., Bissada N., Yang X.W., Paganetti P., Friedlander R.M., Leavitt B.R., Hayden M.R. Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum. Mol. Genet. 2010, 19:1528-1538.
38. Reiner A., Del Mar N., Meade C.A., Yang H., Dragatsis I., Zeitlin S., Goldowitz D. Neurons lacking huntingtin differentially colonize brain and survive in chimeric mice. J. Neurosci. 2001, 21:7608-7619.
39. Reiner A., Dragatsis I., Dietrich P. Genetics and neuropathology of Huntington's disease. Int. Rev. Neurobiol. 2011, 98:325-372.
40. Sah D.W., Aronin N. Oligonucleotide therapeutic approaches for Huntington disease. J. Clin. Invest. 2011, 121:500-507.
41. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., Vonsattel J.P., Aronin N., DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 1997, 42:604-612.
42. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G.P., Davies S.W., Lehrach H., Wanker E.E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997, 90:549-558.
43. Schmitt I., Bächner D., Megow D., Henklein P., Hameister H., Epplen J.T., Riess O. Expression of the Huntington disease gene in rodents: cloning the rat homologue and evidence fr downregulation in non-neuronal tissues during development. Hum. Mol. Genet. 1995, 4:1173-1182.
44. Schulte J., Littleton J.T. The biological function of the Huntington protein and its relevance to Huntington's disease pathology. Curr. Trends Neurol. 2011, 5:65-78.
45. Seong I.S., Woda J.M., Song J.J., Lloret A., Abeyrathne P.D., Woo C.J., Gregory G., Lee J.M., Wheeler V.C., Walz T., Kingston R.E., Gusella J.F., Conlon R.A., MacDonald M.E. Huntingtin facilitated polycomb repressive complex 2. Hum. Mol. Genet. 2010, 19:573-583.
46. Sharp A.H., Loev S.J., Schilling G., Li S.H., Li X.J., Bao J., Wagster M.V., Kotzuk J.A., Steiner J.P., Lo A., et al. Widespread expression of Huntington's disease gene (IT14) protein product. Neuron 1995, 14:1065-1074.
47. Slow E.J., van Raamsdonk J., Rogers D., Coleman S.H., Graham R.K., Deng Y., Oh R., Bissada N., Hossain S.M., Yang Y.Z., Li X.J., Simpson E.M., Gutekunst C.A., Leavitt B.R., Hayden M.R. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 2003, 12:1555-1567.
48. Strong T.V., Tagle D.A., Valdes J.M., Elmer L.W., Boehm K., Swaroop M., Kaatz K.W., Collins F.S., Albin R.L. Widespread expression of the human and rat Huntington's disease gene in brain and nonneuronal tissues. Nat. Genet. 1993, 5:259-265.
49. Suopanki J., Götz C., Lutsch G., Schiller J., Harjes P., Herrmann A., Wanker E.E. Interaction of huntingtin fragments with membranes - clues to early dysfunction in Huntington's disease. J. Neurochem. 2006, 96:870-884.
50. Takano H., Gusella J.F. The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NFkB/Rel/dorsal family transcription factor. BMC Neurosci. 2002, 3:15.
51. Tartari M., Gissi C., Lo Sardo V., Zuccato C., Picardi E., Pesole G., Cattaneo E. Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin. Mol. Biol. Evol. 2008, 25:330-338.
52. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
53. Tong Y., Ha T.J., Liu L., Nishimoto A., Reiner A., Goldowitz D. Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development. J. Neurosci. 2011, 31:14794-14799.
54. Trejo A., Tarrats R.M., Alonso M.E., Boll M.C., Ochoa A., Velásquez L. Assessment of the nutrition status of patients with Hunstington's disease. Nutrition 2004, 20:192-196.
55. Trottier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E.C., Mandel J.L. Cellualr localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat. Genet. 1995, 10:104-110.
56. Van Raamsdonk J.M., Gibson W.T., Pearson J., Murphy Z., Lu G., Leavitt B.R., Hayden M.R. Body weight is modulated by levels of full-length huntingtin. Hum. Mol. Genet. 2006, 15:1513-1523.
57. Van Raamsdonk J.M., Pearson J., Murphy Z., Hayden M.R., Leavitt B.R. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. BMC Neurosci. 2006, 7:80.
58. Van Raamsdonk J.M., Pearson J., Rogers D.A., Bissada N., Vogl A.W., Hayden M.R., Leavitt B.R. Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 2005, 14:1379-1392.
59. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 1998, 57:369-384.
60. Wanker E.E. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol. Chem. 2000, 381:937-942.
61. Wilkinson F.L., Nguyen T.M., Manilal S.B., Thomas P., Neal J.W., Harper P.S., Jones A.L., Morris G.E. Localization of rabbit huntingtin using a new panel of monoclonal antibodies. Brain Res. Mol. Brain Res. 1999, 69:10-20.
62. Woda J.M., Calzonetti T., Hilditch-Maguire P., Duyao M.P., Conlon R.A., MacDonald M.E. Inactivation of the Huntingtin disease gene (Hdh) impairs anterior streak formation and early patterning in the mouse embryo. BMC Dev. Biol. 2005, 5:17.
63. Zeitlin S., Liu J.P., Chapman D.L., Papaioannou V.E., Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 1995, 11:155-163.
64. Zhang Y., Friedlander R.M. Using non-coding small RNAs to develop therapies for Huntington's disease. Gene Ther. 2011, 18:1139-1149.
65. Zhang Y., Leavitt B.R., van Raamsdonk J.M., Dragatsis I., Goldowitz D., MacDonald M.E., Hayden M.R., Friedlander R.M. Huntingtin inhibits caspase-3 activation. EMBO J. 2006, 25:5896-5906.
66. Zhang Y., Li M., Drozda M., Chen M., Ren S., Mejia Sanchez R.O., Leavitt B.R., Cattaneo E., Ferrante R.J., Hayden M.R., Friedlander R.M. Depletion of wild-type huntingtin in mouse models of neurologic diseases. J. Neurochem. 2003, 87:101-106.
67. Zheng S., Clabough E.B., Sarkar S., Futter M., Rubinsztein D.C., Zeitlin S.O. Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet. 2010, 6(2). e1000838.
68. Zuccato C., Ciammola A., Rigamonti D., Leavitt B.R., Goffredo D., Conti L., MacDonald M.E., Friedlander R.M., Silani V., Hayden M.R., Timmusk T., Sipione S., Cattaneo E. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001, 293:493-498.